Mawson Infrastructure Group Inc. (MIGI) - Dilution Analysis

10-K filing | 5.5M shares outstanding

8-K filing: Mawson Infrastructure Group Inc. sold 2,161,379 shares of Common Stock pursuant to the Sales Agreement for aggregate net proceeds of approximately $13.2 million. ($13.2M proceeds)

8-K filing: Mawson Infrastructure Group Inc. increased the capacity of its existing at-the-market offering program by $40,000,000, while having previously sold 1,558,944 shares of Common Stock for aggregate gross proceeds of $9,599,246.43 through Wainwright under the Sales Agreement. ($9.6M proceeds)

8-K filing: Stock split 1-for-20 | Outstanding: 23,602,947 → 1,180,147

10-Q filing | 23.6M shares outstanding

S-3 filing: MAWSON INFRASTRUCTURE GROUP INC. is filing an S-3 registration statement to offer and sell up to $50,000,000 in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings.

10-Q filing | 20.2M shares outstanding

10-Q filing | 18.8M shares outstanding

10-K filing | 17.8M shares outstanding

10-Q filing | 18.5M shares outstanding

10-Q filing | 17.4M shares outstanding

10-Q filing | 16.6M shares outstanding

10-K filing | 15.7M shares outstanding

8-K filing: Mawson Infrastructure Group Inc. granted Restricted Stock Units (RSU) under the 2021 Equity Incentive Plan representing the right to receive 3,629,241 Shares on June 29, 2023, 380,000 Shares on July 14, 2023, 1,506,885 Shares on July 19, 2023 and 115,741 Shares on July 21, 2023.

10-Q filing | 16.5M shares outstanding

10-Q filing | 15.5M shares outstanding

10-Q filing | 16.2M shares outstanding

8-K filing: Mawson Infrastructure Group Inc. completed a registered direct offering and concurrent private placement on May 8, 2023, issuing 2,083,336 shares of common stock and warrants to purchase up to 2,604,170 shares of common stock, resulting in gross proceeds of approximately $5 million. ($5.0M proceeds)

10-K filing | 14.1M shares outstanding

8-K filing: Stock split 1-for-6 | Outstanding: 79,366,725 → 14,027,388

10-Q filing | 79.4M shares outstanding

8-K filing: Mawson Infrastructure Group, Inc. entered into a Purchase and Sale Agreement and an Equipment Purchase and Sale Agreement with CleanSpark, Inc., involving the sale of a property and ASICs for cash, shares of CleanSpark common stock, and seller financing. ($6.5M proceeds)

10-Q filing | 81.2M shares outstanding

8-K filing: Mawson Infrastructure Group Inc. entered into a Securities Purchase Agreement with an institutional investor for the issuance and sale of 8,000,000 shares of common stock at $0.80 per share, along with warrants to purchase 10,000,000 shares of common stock, in a registered direct offering. ($6.4M proceeds)

10-Q filing | 72.5M shares outstanding

S-3/A filing: Mawson Infrastructure Group Inc. files an S-3/A form to offer and sell up to $500,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants and units from time to time in one or more offerings.

S-3 filing: Mawson Infrastructure Group Inc. is filing an S-3 to offer and sell up to $500,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants, and units from time to time in one or more offerings.

10-K filing | 71.6M shares outstanding

8-K filing: Mawson issued warrants to Celsius Mining to purchase up to 3,850,000 shares of common stock at an exercise price of US$6.50 per share.

10-Q filing | 69.0M shares outstanding

S-3 filing: This is an S-3 filing for a shelf offering of common stock by selling stockholders and potential proceeds from warrant exercises.

8-K filing: Mawson Infrastructure Group Inc. completed a public offering of 3,913,044 shares of common stock and accompanying warrants, with the Underwriters exercising their option to purchase 293,478 additional warrants, resulting in net proceeds of approximately $41,234,050 for the Company. ($41.24M proceeds)

8-K filing: Stock split 1-for-10 | Outstanding: 539,192,684 → 58,552,512

10-Q filing | 539.2M shares outstanding

S-3/A filing: Mawson Infrastructure Group Inc. may offer and sell up to $200,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants, and units from time to time in one or more offerings.

S-3 filing: Mawson Infrastructure Group Inc. is filing an S-3 to offer and sell up to $200,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants, and units from time to time in one or more offerings.

S-1/A filing: This prospectus relates to the offer and resale by the selling stockholders identified herein of up to 563,941,835 shares of Common Stock

S-1 filing: This S-1 filing relates to the offer and resale by selling stockholders of up to 563,941,835 shares of common stock.

10-Q filing | 486.7M shares outstanding

10-K filing | 32.8M shares outstanding

8-K filing: Wize Pharma, Inc. commenced an off-market takeover offer to acquire all outstanding shares of Cosmos Capital Limited, offering 61.11 shares of Wize's common stock, with 22.33 shares subject to a Stock Restriction Agreement.

8-K filing: Wize Pharma, Inc. amended the Bid Implementation Agreement with Cosmos Capital Limited, modifying the Offer Consideration to 61.11 shares of Wize's common stock per Cosmos Share, with 22.33 shares subject to a Stock Restriction Agreement.

8-K filing: Wize Pharma entered into a Bid Implementation Agreement with Cosmos Capital Limited to acquire Cosmos shares in exchange for Wize common stock and warrants, and also entered into Securities Purchase Agreements with accredited investors to sell 25,000,000 shares of common stock at $0.12 per share for gross proceeds of $3.0 million. ($3.0M proceeds)

8-K filing: Wize Pharma, Inc. reduced the exercise price of certain warrants to $0.001 per share until January 7, 2021, resulting in the issuance of 13,332,657 shares upon exercise of such warrants on December 29, 2020.

8-K filing: Wize Pharma, Inc. entered into exchange agreements with certain holders of common stock purchase warrants to purchase an aggregate of 3,000,000 shares of the Company's common stock, with the holders surrendering their warrants for cancellation and receiving 3,000,000 restricted shares of common stock as consideration.

10-Q filing | 15.9M shares outstanding

10-Q filing | 15.9M shares outstanding

8-K filing: Wize Pharma, Inc. redeemed all of its Series B Non-Voting Redeemable Preferred Stock and distributed 68,191,200 Bonus Shares to the former holders of the Preferred Stock, resulting in the Company beneficially owning 17,047,800 Bonus Shares, representing approximately 1.76% of the outstanding shares of Bonus BioGroup Ltd.

10-Q filing | 16.0M shares outstanding

10-K filing | 15.9M shares outstanding

8-K filing: Wize Pharma, Inc. closed its previously announced transactions, including the sale of 37% of future revenues from its L02A-based products to Bonus BioGroup Ltd. and an investment of $7.4 million in Bonus, and the issuance of 7,500 shares of newly created Series B Non-Voting Redeemable Preferred Stock for aggregate gross proceeds of $7.5 million. ($7.5M proceeds)

8-K filing: Wize Pharma, Inc. entered into agreements with Bonus BioGroup Ltd. involving the sale of future revenues from its L02A-based products and an investment in Bonus, and a separate agreement to sell Series B Preferred Stock to accredited investors to finance the Bonus transaction. ($7.5M proceeds)